Prognosis prediction for patients with cardiovascular and cerebrovascular diseases using multi-omics

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect clinical and biological specimen data from patients diagnosed with various cardiovascular and cerebrovascular diseases. By employing multi-omics technology, the study seeks to uncover the underlying pathogenic mechanisms of these diseases. The ultimate goal is to develop early predictive prognostic models that can inform individualized treatment strategies for affected patients. This research addresses the significant public health challenge posed by cardiovascular diseases and aims to enhance diagnosis and treatment options.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients who are regularly visited and followed up in the appropriate patient; department.
* All patients met at least one of the following diagnostic criteria for cardiovascular and cerebrovascular diseases:
* coronary artery disease group;
* arrhythmia group;
* heart valve disease group;
* aortic dissection group;
* cardiac masses group;
* myocarditis group;
* hypertension group;
* cardiomyopathy group;
* structural heart disease group;
* ischemic cerebrovascular disease group;
* hemorrhagic cerebrovascular disease group;
* intracranial space occupying lesion group.

Exclusion Criteria:

* Age \<3 years or \>80 years old;
* Pregnant and lactating women;
* The patient declined to provide informed consent to participate in the study;
* None of the above was met, but the patient was temporarily unable to sign the informed consent form due to coma and other reasons, and no legal representative signed it instead. Depending on the patient's condition, the patient may not be able to regain consciousness and sign the informed consent form.

Where it's running

• First Affiliated Hospital of Xian Jiantong University
  Xi'an, Shaanxi, China Recruiting

Study contacts

• Principal investigator: Gouliang Li — First Affiliated Hospital Xi'an Jiaotong University
• Study coordinator: Gouliang Li
• Email: liguoliang_med@163.com
• Phone: 13759982523

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Multimodal Cardiac MRI to See How the Heart Is Working

  This study tests a comprehensive MRI approach to characterize heart structure and tissue in adults with suspected or confirmed cardiovascular disease.

  Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07617844

• Managing multiple medications in older adults with chronic diseases

  This project will see if taking many different medicines changes the health outlook of people aged 65 and older who have chronic conditions.

  Recruiting Xijing Hospital · Xi'an, Shaanxi · NCT07180368

• Evaluating endomyocardial biopsy and tailored treatments for pediatric inflammatory heart disease

  This study is testing how a heart tissue sample and personalized treatments can help kids with inflammatory heart disease, especially those with myocarditis and heart rhythm issues.

  Recruiting Scientific Institute San Raffaele · Milan, Milano · NCT06591260

• Pharmacy-led intervention to improve medication adherence after hospital discharge

  This study tests a pharmacy-led program to help low-income patients with multiple chronic conditions take their medications correctly after leaving the hospital.

  Recruiting University of Tennessee · Knoxville, Tennessee and 1 other locations · NCT06374277

• Stereotactic body radiation therapy versus catheter ablation for ventricular tachycardia in structural heart disease

  This trial will test whether a focused radiation treatment (SBRT) can reduce ventricular tachycardia episodes more than standard catheter ablation in people with advanced structural heart disease.

  Recruiting Western Sydney Local Health District · Westmead · NCT06360939

• Using low-dose aspirin after preeclampsia to improve recovery

  This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.

  Recruiting Phase 4 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT06281665

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.